4//SEC Filing
Scalzo Richard William 4
Accession 0000950170-24-105123
CIK 0001818794other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:05 PM ET
Size
31.8 KB
Accession
0000950170-24-105123
Insider Transaction Report
Form 4
Scalzo Richard William
SVP, Head of Finance & Admin.
Transactions
- Exercise/Conversion
Common Stock
2024-09-06$10.72/sh+18,750$201,000→ 220,948 total - Exercise/Conversion
Common Stock
2024-09-06$10.88/sh+6,552$71,286→ 227,500 total - Exercise/Conversion
Common Stock
2024-09-06$5.54/sh+6,502$36,021→ 117,524 total - Exercise/Conversion
Common Stock
2024-09-06$5.54/sh+3,353$18,576→ 120,877 total - Sale
Common Stock
2024-09-06$32.63/sh−1,700$55,471→ 101,426 total - Exercise/Conversion
Stock option (right to buy)
2024-09-06−3,353→ 0 totalExercise: $5.54Exp: 2030-07-30→ Common Stock (3,353 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-09-06−29,792→ 25,208 totalExercise: $8.58Exp: 2032-07-10→ Common Stock (29,792 underlying) - Exercise/Conversion
Common Stock
2024-09-06$19.00/sh+34,833$661,827→ 155,710 total - Exercise/Conversion
Common Stock
2024-09-06$13.12/sh+16,696$219,052→ 172,406 total - Exercise/Conversion
Common Stock
2024-09-06$8.58/sh+29,792$255,615→ 202,198 total - Sale
Common Stock
2024-09-06$32.14/sh−124,374$3,997,380→ 103,126 total - Exercise/Conversion
Stock option (right to buy)
2024-09-06−34,833→ 742 totalExercise: $19.00Exp: 2030-09-15→ Common Stock (34,833 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-09-06−16,696→ 8,348 totalExercise: $13.12Exp: 2031-12-09→ Common Stock (16,696 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-09-06−6,502→ 0 totalExercise: $5.54Exp: 2030-07-30→ Common Stock (6,502 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-09-06−18,750→ 26,250 totalExercise: $10.72Exp: 2032-12-08→ Common Stock (18,750 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-09-06−6,552→ 28,394 totalExercise: $10.88Exp: 2033-11-14→ Common Stock (6,552 underlying)
Footnotes (9)
- [F1]Includes 101,426 unvested RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $31.62 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- [F3]The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024, provided that no shares shall vest prior to December 2, 2020.
- [F4]The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024, provided that no shares shall vest prior to December 2, 2020.
- [F5]The option was granted on September 16, 2020. The shares underlying the option vest over four years in equal monthly installments through September 16, 2024.
- [F6]The option was granted on December 10, 2021. The shares underlying the option vest over four years in equal monthly installments through December 10, 2025.
- [F7]The option was granted on July 11, 2022. The shares underlying the option vest over four years in equal monthly installments beginning on July 1, 2022.
- [F8]The option was granted on December 9, 2022. The shares underlying the option vest over four years in equal monthly installments through December 10, 2026.
- [F9]The option was granted on November 15, 2023. The shares underlying the option vest over four years in equal monthly installments through November 15, 2027.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001789545
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:05 PM ET
- Size
- 31.8 KB